Why Is GOSSAMER BIO INC (GOSS) Stock Moving Today?
By the Top Tier Newswire AI Desk · September 11, 2026 at 1:43 PM ET · reviewed against 4 wire stories
GOSSAMER BIO INC (GOSS) is drawing unusual attention today. Our newswire has captured 4 stories on GOSS across 4 sources in the last 36 hours, with AI sentiment reading bearish (avg 38/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Gossamer Bio (GOSS) stock is moving sharply higher today after the company executed a 1-for-80 reverse stock split and share reduction. The stock opened at $8.03, a 5,539.1% increase from the prior close of $0.14, and reached a session high of $13.25 shortly after the market opened. The move is tied to the company’s announcement that the reverse split became effective on September 10, reducing authorized shares from 4 billion to 50 million.
What Happened
Gossamer Bio implemented a 1-for-80 reverse stock split on September 10, 2026, as disclosed in an SEC 8-K filing on September 11. The company also announced that its stock must close at or above $1 for at least 10 consecutive business days to regain compliance with listing requirements by October 5. The stock was halted before the market opened, with news pending, and reopened at a significantly higher price. The reverse split is part of a broader effort to restructure the company’s capital and meet regulatory requirements.
What The Data Shows
Intraday trading showed a dramatic gap up, with the stock opening at $8.03 and reaching $13.25 within minutes. The 52-week range for the stock is $0.11 to $3.87, indicating the current price is well above historical levels. Over the last eight sessions, the stock had declined 17.0% from $0.22 to $0.18. There has been no significant social media chatter in the last 24 hours, and only one post in the last seven days.
What To Watch
The stock will continue to be monitored for its ability to maintain a price above $1 for 10 consecutive business days to meet compliance goals. Investors should also watch for further updates on the company’s $250 million structured private placement and any upcoming FDA milestones that may impact its financing plans.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
GOSS · Sep 11 session (5-min) · +7411.24% vs prior close · updated 8:58 PM ETAI sentiment, last 36h · averaged over 4 stories · 38/100 bearish
The headlines behind the move
Story flow · 4 stories on the wire, last 36h · hover or tap a dot for the headline
1d agoTipRanksBEARISH 25General
Gossamer Bio Executes Reverse Stock Split and Share Reduction
The latest announcement is out from Gossamer Bio ( ($GOSS) ). On September 10, 2026, Gossamer Bio implemented a 1-for-80 reverse stock split of its common stock and...
2d agoSEC 8-KNEUTRAL 50General
Gossamer Bio, Inc. (GOSS) files 8-K
Filed: 2026-09-11 AccNo: 0001728117-26-000094 Size: 194 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
2d agoStockTitanBEARISH 25General
Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split
Authorized shares dropped from 4 billion to 50 million, while Gossamer says its stock must close at least $1 for 10 straight business days to regain compliance by Oct. 5.
2d agoThe FlyNEUTRAL 50General
Gossamer Bio trading halted, news pending
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →